Harm C.A. Graat

612 total citations
17 papers, 470 citations indexed

About

Harm C.A. Graat is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Harm C.A. Graat has authored 17 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Harm C.A. Graat's work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Harm C.A. Graat is often cited by papers focused on Virus-based gene therapy research (7 papers), CAR-T cell therapy research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Harm C.A. Graat collaborates with scholars based in Netherlands, United States and France. Harm C.A. Graat's co-authors include Victor W. van Beusechem, Gertjan J.L. Kaspers, Marco N. Helder, Peter A. Nolte, Diederik A. Vergroesen, Edgar J.G. Peters, Y. J. Debets-Ossenkopp, Jesse W.P. Kuiper, Frederik H.E. Schagen and Jantine PosthumaDeBoer and has published in prestigious journals such as Spine, British Journal of Cancer and Virology.

In The Last Decade

Harm C.A. Graat

17 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harm C.A. Graat Netherlands 11 206 191 117 101 36 17 470
Moujtaba Y. Kasmani United States 15 69 0.3× 136 0.7× 185 1.6× 74 0.7× 24 0.7× 22 580
Tsutomu Kanefuji Japan 11 73 0.4× 170 0.9× 59 0.5× 85 0.8× 26 0.7× 30 322
Mariela Artola-Borán Switzerland 12 140 0.7× 309 1.6× 68 0.6× 43 0.4× 23 0.6× 15 599
Vikas Satyananda United States 12 284 1.4× 222 1.2× 160 1.4× 178 1.8× 92 2.6× 25 637
M Tavassoli United Kingdom 11 70 0.3× 215 1.1× 203 1.7× 57 0.6× 32 0.9× 13 532
R Laguens Argentina 13 236 1.1× 228 1.2× 67 0.6× 64 0.6× 44 1.2× 25 577
J H Lee United States 4 71 0.3× 227 1.2× 236 2.0× 151 1.5× 26 0.7× 4 500
Chikako Tanabe Japan 9 101 0.5× 350 1.8× 83 0.7× 88 0.9× 63 1.8× 9 515
Fernando C. L. Carapeto United States 9 94 0.5× 113 0.6× 132 1.1× 36 0.4× 35 1.0× 22 263
Ryohei Nishino Japan 4 61 0.3× 134 0.7× 114 1.0× 44 0.4× 62 1.7× 12 354

Countries citing papers authored by Harm C.A. Graat

Since Specialization
Citations

This map shows the geographic impact of Harm C.A. Graat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm C.A. Graat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm C.A. Graat more than expected).

Fields of papers citing papers by Harm C.A. Graat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harm C.A. Graat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm C.A. Graat. The network helps show where Harm C.A. Graat may publish in the future.

Co-authorship network of co-authors of Harm C.A. Graat

This figure shows the co-authorship network connecting the top 25 collaborators of Harm C.A. Graat. A scholar is included among the top collaborators of Harm C.A. Graat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harm C.A. Graat. Harm C.A. Graat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kroeze, Robert Jan, et al.. (2017). Interobserver and Intraobserver Reliability in the Radiologic Assessment of Lumbar Interbody Fusion. Clinical Spine Surgery A Spine Publication. 30(6). E853–E856. 9 indexed citations
2.
Temmerman, Olivier P.P., Marco J.M. Hoozemans, Bart J. Burger, et al.. (2017). Inter- And Intraobserver Reliability In The Assessment Of Glenoid Fracture Classifications.. PubMed. 83(4). 605–611. 1 indexed citations
3.
Graat, Harm C.A., et al.. (2016). Superior dislocation of the patella: a pathognomonic finding and review of literature. Skeletal Radiology. 46(2). 259–264. 4 indexed citations
4.
Graat, Harm C.A., Janneke J. P. Schimmel, Roel J. W. Hoogendoorn, et al.. (2015). Poor Radiological and Good Functional Long-term Outcome of Surgically Treated Scheuermann Patients. Spine. 41(14). E869–E878. 14 indexed citations
5.
Hessem, Lotte van, Janneke J. P. Schimmel, Harm C.A. Graat, & Marinus de Kleuver. (2014). Effective nonoperative treatment in juvenile idiopathic scoliosis. Journal of Pediatric Orthopaedics B. 23(5). 454–460. 10 indexed citations
6.
Kuiper, Jesse W.P., Diederik A. Vergroesen, Harm C.A. Graat, et al.. (2013). Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention). Acta Orthopaedica. 84(4). 380–386. 131 indexed citations
7.
PosthumaDeBoer, Jantine, Thomas Würdinger, Harm C.A. Graat, et al.. (2011). WEE1 inhibition sensitizes osteosarcoma to radiotherapy. BMC Cancer. 11(1). 156–156. 101 indexed citations
8.
PosthumaDeBoer, Jantine, et al.. (2010). Small cell osteosarcoma of a toe phalanx: a case report and review of literature. Journal of Orthopaedic Surgery and Research. 5(1). 36–36. 4 indexed citations
9.
Graat, Harm C.A., Victor W. van Beusechem, Frederik H.E. Schagen, et al.. (2008). Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases. Molecular Cancer. 7(1). 9–9. 15 indexed citations
10.
Schagen, Frederik H.E., Harm C.A. Graat, Jan E. Carette, et al.. (2008). Replacement of Native Adenovirus Receptor-Binding Sites with a New Attachment Moiety Diminishes Hepatic Tropism and Enhances Bioavailability in Mice. Human Gene Therapy. 19(8). 783–794. 7 indexed citations
11.
Graat, Harm C.A., Jan E. Carette, Frederik H.E. Schagen, et al.. (2007). Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53. Molecular Cancer Therapeutics. 6(5). 1552–1561. 31 indexed citations
12.
Graat, Harm C.A., M.A. Witlox, Frederik H.E. Schagen, et al.. (2006). Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin. British Journal of Cancer. 94(12). 1837–1844. 37 indexed citations
13.
Schagen, Frederik H.E., et al.. (2006). 15. Genetically Targeted Adenovirus Vector Carrying Reovirus σ1-Based Attachment Protein for Improved Systemic Gene Delivery. Molecular Therapy. 13. S6–S7. 1 indexed citations
14.
Carette, Jan E., Harm C.A. Graat, Frederik H.E. Schagen, et al.. (2006). A conditionally replicating adenovirus with strict selectivity in killing cells expressing epidermal growth factor receptor. Virology. 361(1). 56–67. 22 indexed citations
15.
Carette, Jan E., Harm C.A. Graat, Frederik H.E. Schagen, et al.. (2005). Replication‐dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice‐acceptor site. The Journal of Gene Medicine. 7(8). 1053–1062. 27 indexed citations
16.
Graat, Harm C.A., Lodewijk W. van Rhijn, Connie Schrander‐Stumpel, & André van Ooij. (2002). Classical Scheuermann Disease in Male Monozygotic Twins. Spine. 27(22). E485–E487. 27 indexed citations
17.
Graat, Harm C.A., André van Ooij, Gregory A. Day, & Ian McPhee. (2002). Nocardia farcinica Spinal Osteomyelitis. Spine. 27(10). E253–E257. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026